Medeor Therapeutics is a private, late clinical stage, biotechnology company dedicated to the discovery, development, and commercialization of transformative and personalized cellular immunotherapies.
Total raised: $57M
Investors 2
| Date | Name | Website |
| - | Sofinnova ... | sofinnova.... |
| 14.09.2021 | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.11.2017 | Series B | $57M | - |
Mentions in press and media 3
| Date | Title | Description |
| 28.11.2017 | Term Sheet — Tuesday, November 28 | THREE THINGS Good morning, Term Sheet readers! Paid Content You can't secure what you can't see From ExtraHop From a seller’s standpoint, the value proposition [for the SoftBank tender offer] is that they are able to liquidate their holding... |
| 28.11.2017 | Medeor Therapeutics Raises $57M In Series B Financing | - |
| 27.11.2017 | Medeor Therapeutics Raises $57M in Series B Financing | Medeor Therapeutics, Inc., a San Mateo, CA-based clinical-stage biotechnology company dedicated to the discovery, development and commercialization of personalized cellular immunotherapies, closed a $57m Series B financing. The round was le... |